Showing results (161-170 of 175) with videos related to
Sort By:
Pageof 18
Pediatric Research|August 31, 2017
Enhancing clinical trial development for pediatric kidney diseasesH William Schnaper, Joseph T Flynn, Coleman Gross, et al.Plos One|May 12, 2017
Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutininPawel Zmora, Paulina Molau-Blazejewska, Stephanie Bertram, et al.Journal of Immunotoxicology|December 10, 2024
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathwaysAlexander Mazein, Muhammad Shoaib, Miriam Alb, et al.Circulation|June 11, 2015
Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) TrialSharon M Moe, Glenn M Chertow, Patrick S Parfrey, et al.Journal of Human Hypertension|June 5, 2015
The effects of cinacalcet on blood pressure, mortality and cardiovascular endpoints in the EVOLVE trialT I Chang, S Abdalla, G M London, et al.The Journal of Clinical Endocrinology and Metabolism|October 11, 2013
The clinical course of treated hyperparathyroidism among patients receiving hemodialysis and the effect of cinacalcet: the EVOLVE trialPatrick S Parfrey, Glenn M Chertow, Geoffrey A Block, et al.European Journal of Human Genetics : EJHG|October 23, 2003
Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypesSeval Türkmen, Gabriele Gillessen-Kaesbach, Peter Meinecke, et al.Hemodialysis International. International Symposium on Home Hemodialysis|November 14, 2015
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trialPatrick H Pun, Safa Abdalla, Geoffrey A Block, et al.Journal of the American Heart Association|November 19, 2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trialDavid C Wheeler, Gerard M London, Patrick S Parfrey, et al.Molecular Therapy. Nucleic Acids|October 22, 2019
Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac FibrosisFranziska Kenneweg, Claudia Bang, Ke Xiao, et al.Pageof 18